DE-BIOCORP
19.2.2020 18:02:08 CET | Business Wire | Press release
Regulatory News:
BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, today announced an alliance with US-based iSage Rx, LLC., a digital therapeutics company, focused on insulin dose optimization.
In detail, the two companies are committed to integrating their respective technologies to simplify insulin dose capture and optimization. The integration of Mallya (a CE-marked connected device dedicated to insulin pens) into the iSage app (a clinically validated insulin titration platform cleared by the FDA) should enable patients with type 2 diabetes to simplify their insulin management.
This will allow patients with diabetes to seamlessly capture, record, and store information about their insulin injections and while receiving automated guidance on how to adjust their insulin dose overtime ("titration").
Ryan Sysko, President and CEO of Amalgam Rx, Inc, said: "We are very pleased with this partnership to interface Mallya with our iSage app. Combining these two solutions offers to date the most powerful environment for diabetes digitalization and patient support. Together, we can simplify the often complex and confusing journey for patients starting on basal insulin. “
Éric Dessertenne, CEO of BIOCORP, concluded: "For patients with diabetes, the integration of Mallya and iSage provides an additional brick of information to improve their quality of life. For the community of diabetes, this integration is a powerful service platform that takes into account all the clinical and behavioral needs of patients. "
ABOUT ISAGE RX
iSage Rx, manufacturers of the iSage App, the first FDA 510(k)-cleared, prescription-only mobile application for the automated titration of all brands of basal insulin. iSage allows physicians to choose from multiple clinically-validated basal insulin algorithms and tailor the algorithms to the specific needs of their type 2 diabetes patients. iSage Rx is a wholly-owned subsidiary of Amalgam Rx. For more information, visit http://isageapp.com .
ABOUT AMALGAM RX
Amalgam Rx creates custom digital therapies that combine clinical and behavioral health and interventions to engage, support, and improve patient self-management. Led by an experienced team of physicians, behaviorists, technologists, and digital health pioneers, Amalgam Rx strives to use technology to accelerate the impact and scale of medicine to improve the lives of millions of people living with chronic disease. Amalgam does this by partnering with leading life sciences companies to accelerate the R&D and commercialization of digital therapeutics. For more information, visit http://amalgamrx.com/ .
ABOUT BIOCORP
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions.
BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR).
For more information, please visit www.biocorpsys.com
.
Follow us on Twitter @BIOCORPSystems
View source version on businesswire.com: https://www.businesswire.com/news/home/20200219005728/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Netceed Publishes Its First Environmental, Social and Governance Report22.4.2026 09:30:00 CEST | Press release
Netceed, a global infrastructure supply chain solutions provider, has published our first Annual Environmental, Social and Governance (ESG) Report, marking a major milestone in the Group’s sustainability journey and reinforcing our commitment to transparency, accountability, and responsible business practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422579806/en/ Netceed Sustainability Report 2025 The report presents Netceed’s progress across environmental, social, and governance topics, including the verification of its carbon footprint data by an independent third party and the completion of its first climate risk analysis. Key highlights include: A reduction in Scope 1 and 2 CO2e emissions compared to 2024 Improved gender diversity in senior management positions – we now have 23% of senior management positions filled by women 70% of our suppliers (by spend) are working with us on our climate action priorities A
IONCHI byder AITO velkommen til at gå sammen med BMW og Mercedes-Benz om at udvikle premium høj-effekt opladningsnetværk i Kina22.4.2026 09:21:00 CEST | Pressemeddelelse
IONCHI, et joint venture mellem BMW og Mercedes-Benz inden for høj-effekt opladningstjenester, annoncerede i dag, at SERES vil tiltræde selskabet som en ligeværdig aktionær. Gennem denne kapitalinvestering vil AITO, premium-brandet fra SERES Group, støtte udviklingen af IONCHIs premium opladningsinfrastruktur. Med denne udvidelse fortsætter IONCHI med at levere premium opladningstjenester gennem avanceret teknologi og digitale services til alle kvalificerede køretøjer, samtidig med at der tilbydes eksklusive opladningsoplevelser til kunder hos BMW, AITO og Mercedes-Benz. Det udvidede trepartssamarbejde markerer begyndelsen på et nyt kapitel for premium opladningsnetværket og muliggør yderligere vækst samt en bredere kundedækning. Hver af de tre aktionærer vil eje en andel på 33,3 % i joint venturet. Etableret i 2024 har IONCHI til formål at løfte Kinas premium-oplevelse inden for elektrisk mobilitet gennem et avanceret offentligt høj-effekt opladningsnetværk. Netværket prioriterer attr
Europcar Mobility Group Announces Exclusive Partnership With MIC Co., Ltd. to Expand Presence in Japan22.4.2026 09:02:00 CEST | Press release
Europcar Mobility Group has entered into an exclusive partnership agreement with MIC Co., Ltd., the operator of Japan’s extensive "Niconico Rent-A-Car" network. This landmark agreement marks Europcar Mobility Group’s first exclusive partnership in the Japanese market, aimed at providing seamless mobility solutions for the growing number of international travelers visiting the region. Enhancing possibilities for Inbound Travelers Since April 10, 2026, customers can book car rentals at Niconico Rent-A-Car’s directly-operated airport locations through Europcar’s global booking platform, allowing foreign travelers to arrange their transportation in Japan from overseas using a familiar interface, eliminating common booking hurdles and improving the overall travel experience.To date, the service is available across key gateway locations: Major Airports: Haneda, Narita, New Chitose, Fukuoka, Kagoshima, Nagasaki, and Kumamoto. Key Transit Hubs: Shin-Yokohama Station and Kansai Airport Rinku To
SkySparc Acquires Covarius and Uniun22.4.2026 09:00:00 CEST | Press release
SkySparc's OmniFi, Covarius and Uniun to anchor an expanded offering for corporate treasury clients SkySparc, a trusted global provider of digital transformation solutions for treasury and finance institutions, today announced the acquisition of Covarius Group Limited (“Covarius”) and Uniun Technology Limited (“Uniun”). The acquisitions accelerate SkySparc’s European expansion and deepen its specialist support for treasury transformation. Financial terms were not disclosed. Covarius and Uniun operate complementary businesses together enabling a more complete, end-to-end treasury solution. Covarius specialises in the implementation and optimisation of treasury management systems, underpinned by deep partnerships and a well-established global presence. Uniun adds a real-time, API-based integration platform focused on ERP-to-TMS connectivity and cash forecasting, supported by AI and data science. For clients, the combined proposition the two companies bring centres on improved cash visibi
Bureau Veritas: A Steady Organic Revenue Growth in the First Quarter 202622.4.2026 07:30:00 CEST | Press release
An evolving macro-environment and a transitioning portfolio mix;Updated 2026 outlook Bureau Veritas (BOURSE:BVI): Q1 2026 Key figures1 › Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year › Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, › Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), › Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies. Q1 2026 Highlights › Maintained steady performance across most regions, in an environment marked by disruptions related to the conflict in the Middle East; growth in the Industry business impacted by the delays of Opex-related services mainly in the Middle East, › Continued progress in execution of the Group’s LEAP | 28 strategy, pivo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom